The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Open accessAbstract
Interpretation of clinical trials comparing different drug regimens for Parkinson's disease (PD) is complicated by the different dose intensities used: higher doses of levodopa and, possibly, other drugs produce better symptomatic control but more late complications. To address this problem, conversion factors have been calculated for antiparkinsonian drugs that yield a total daily levodopa equivalent dose (LED). LED estimates vary, so we undertook a systematic review of studies reporting LEDs to provide standardized formulae. Electronic database and hand searching of references identified 56 primary reports of LED estimates. Data were extracted and the mean and modal LEDs calculated. This yielded a standardized LED for each drug, providing a useful tool to express dose intensity of different antiparkinsonian drug regimens on a single scale. Using these conversion formulae to report LEDs would improve the consistency of reporting and assist the interpretation of clinical trials comparing different PD medications. © 2010 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
Krack, P. (1998) · Brain · doi:10.1093/brain/121.3.451 · Cited by 608
Effect of GPi pallidotomy on motor function in Parkinson's disease
Lozano, A. M., Lang, A. E., Galvez-Jimenez, N., Miyasaki, J., Duff, J., Hutchison, W. D., & Dostrovsky, J. O. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92404-3 · Cited by 603
Baron, M. S., Vitek, J. L., Green, J., Kaneoke, Y., Hashimoto, T., Turner, R. S., Woodard, J. L., Delong, M. R., Bakay, R. A. E., Cole, S. A., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400305 · Cited by 558
Hobson, D. E., Lang, A. E., Martin, W. R. W., Razmy, A., Rivest, J., & Fleming, J. (2002) · JAMA · doi:10.1001/jama.287.4.455 · Cited by 553
Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease
Lang, A. E., Lozano, A. M., Montgomery, E., Duff, J., Tasker, R., & Hutchinson, W. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371503 · Cited by 483
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A. H., Katzenschlager, R., Paviour, D., O'Sullivan, J. D., Appel, S., Lawrence, A. D., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20045 · Cited by 474
Dyskinesias following neural transplantation in Parkinson's disease
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L., Pavese, N., Oertel, W. H., Quinn, N., et al. (2002) · Nature Neuroscience · doi:10.1038/nn863 · Cited by 443
Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease
Moro, E., Scerrati, M., Romito, L. M. A., Roselli, R., Tonali, P., & Albanese, A. (1999) · Neurology · doi:10.1212/wnl.53.1.85 · Cited by 420
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A., Katzenschlager, R., Paviour, D. C., Appel‐Cresswell, S., Lawrence, A., & Lees, A. J. (2004) · UCL Discovery (University College London) · Cited by 401
Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up
Vingerhoets, F. J. G., Villemure, J.-G., Temperli, P., Pollo, C., Pralong, E., & Ghika, J. (2002) · Neurology · doi:10.1212/wnl.58.3.396 · Cited by 314
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
Katzenschlager, R., Head, J., Schrag, A., Ben-Shlomo, Y., Evans, A., & Lees, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310812.43352.66 · Cited by 271
Long-Term Follow-up of Unilateral Pallidotomy in Advanced Parkinson's Disease
Fine, J., Duff, J., Chen, R., Hutchison, W., Lozano, A. M., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422304 · Cited by 266
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial
Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Lenders, M. W. P. M., Nijssen, P. C. G., Staal, M. J., Smeding, H. M. M., Schuurman, P. R., Bosch, D. A., & Speelman, J. D. (2004) · Neurology · doi:10.1212/01.wnl.0000103235.12621.c3 · Cited by 254
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease
Vitek, J. L., Bakay, R. A. E., Freeman, A., Evatt, M., Green, J., McDonald, W., Haber, M., Barnhart, H., Wahlay, N., Triche, S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10517 · Cited by 243
Krause, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.4.464 · Cited by 233
Giladi, N., Boroojerdi, B., Korczyn, A. D., Burn, D. J., Clarke, C. E., Schapira, A. H. V., & SP513 investigators (2007) · Movement Disorders · doi:10.1002/mds.21741 · Cited by 227
Self-citationØstergaard, K., Sunde, N., & Dupont, E. (2002) · Movement Disorders · doi:10.1002/mds.10188 · Cited by 217
Subthalamic nucleus stimulation in Parkinson's disease
Thobois, S., Mertens, P., Guenot, M., Hermier, M., Mollion, H., Bouvard, M., Chazot, G., Broussolle, E., & Sindou, M. (2002) · Journal of Neurology · doi:10.1007/s004150200059 · Cited by 199
Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial
de Bie, R. M., de Haan, R. J., Nijssen, P. C., Rutgers, A. W. F., Beute, G. N., Bosch, D. A., Haaxma, R., Schmand, B., Schuurman, P. R., Staal, M. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03556-4 · Cited by 177
Sleepiness in Parkinson's disease: A controlled study
Brodsky, M. A., Godbold, J., Roth, T., & Olanow, C. W. (2003) · Movement Disorders · doi:10.1002/mds.10429 · Cited by 169
Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up
Pahwa, R., Wilkinson, S. B., Overman, J. W., & Lyons, K. E. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.1.0071 · Cited by 144
Parkin, S., Gregory, R., Scott, R., Bain, P., Silburn, P., Hall, B., Boyle, R., Joint, C., & Aziz, T. (2002) · Movement Disorders · doi:10.1002/mds.10186 · Cited by 133
The perception of passive motion in Parkinson's disease
Konczak, J., Krawczewski, K., Tuite, P., & Maschke, M. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0426-2 · Cited by 120
Baron, M. S., Vitek, J. L., Bakay, R. A. E., Green, J., McDonald, W. M., Cole, S. A., & DeLong, M. R. (2000) · Movement Disorders · Cited by 114
Restless legs syndrome in Parkinson's disease
Peralta, C., Frauscher, B., Seppi, K., Wolf, E., Wenning, G. K., Högl, B., & Poewe, W. H. (2009) · Movement Disorders · doi:10.1002/mds.22694 · Cited by 111
Grosset, K. A., Needleman, F., Macphee, G. J. A., & Grosset, D. G. (2004) · Movement Disorders · doi:10.1002/mds.20210 · Cited by 105
Tir, M., Devos, D., Blond, S., Touzet, G., Reyns, N., Duhamel, A., Cottencin, O., Dujardin, K., Cassim, F., Destée, A., et al. (2007) · Neurosurgery · doi:10.1227/01.neu.0000285347.50028.b9 · Cited by 105
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France
Ghorayeb, I., Loundou, A., Auquier, P., Dauvilliers, Y. A., Bioulac, B. H., & Tison, F. (2007) · Movement Disorders · doi:10.1002/mds.21541 · Cited by 104
Stowe, R. L., Ives, N. J., Clarke, C. E., Deane, K. H., van Hilten, Wheatley, K., Gray, R. G., Handley, K., & Furmston, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007166.pub2 · Cited by 103
Self-citationForce overflow and levodopa‐induced dyskinesias in Parkinson’s disease
Wenzelburger, R., Zhang, B., Pohle, S., Klebe, S., Lorenz, D., Herzog, J., Wilms, H., Deuschl, G., & Krack, P. (2002) · Brain · doi:10.1093/brain/awf084 · Cited by 102
Use and interpretation of on/off diaries in Parkinson's disease
Reimer, J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.022780 · Cited by 85
Impulse control disorders in Parkinson's disease in a Chinese population
Fan, W., Ding, H., Ma, J., & Chan, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.074 · Cited by 72
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
Parkes, J. D., Baxter, R. C., MARSDEN, C. D., et al. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.4.422 · Cited by 61
Matsui, H., Nishinaka, K., Oda, M., Komatsu, K., Kubori, T., & Udaka, F. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.12.008 · Cited by 60
Castro‐Caldas, A., Delwaide, P. J., Jost, W. H., Merello, M., Williams, A. C., Lamberti, P., Aguilar, M., Signore, S. D., & Césaro, P. (2005) · Movement Disorders · doi:10.1002/mds.20750 · Cited by 56
Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease
Mutez, E., Duhamel, A., Defebvre, L., Bordet, R., Destée, A., & Kreisler, A. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.010 · Cited by 51
Pharmacotherapy of Parkinson’s disease in Germany
Möller, J. C., Körner, Y., Dodel, R. C., Meindorfner, C., Stiasny‐Kolster, K., Spottke, A. E., Krüger, H. P., & Oertel, W. H. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0784-1 · Cited by 49
Romito, L. M., Scerrati, M., Contarino, M. F., Iacoangeli, M., Bentivoglio, A. R., & Albanese, A. (2003) · PubMed · Cited by 46
Relationship between age and subtypes of psychotic symptoms in Parkinson's disease
Kızıltan, G., Özekmekçi, S., Ertan, S., Ertan, T., & Erginöz, E. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0388-4 · Cited by 39
Bilateral subthalamotomy for advanced Parkinson disease
Tseng, H., Su, P. C., Liu, H., Liou, H., & Yen, R. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2007.05.058 · Cited by 33
Lee, J., Jeon, B. S., Paek, S. H., Lim, Y. H., Kim, M.-R., & Kim, C. (2009) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.10.008 · Cited by 31
Cabrini, S., Baratti, M., Bonfà, F., Cabri, G., Uber, E., & Avanzi, M. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0101-3 · Cited by 28
Çoban, A., Hanağası, H., Karamürsel, S., & Barlas, O. (2009) · British Journal of Neurosurgery · doi:10.1080/02688690802507775 · Cited by 27
Hallucinations in Parkinson's disease--a study of forty three patients.
Gupta, M., Singh, G., Khwaja, G. A., & Mehndiratta, M. (2004) · PubMed · Cited by 21
Medications used to treat Parkinson’s disease and the risk of gambling
Imamura, A., Geda, Y. E., Slowinski, J. L., Wszołek, Z. K., Brown, L., & Uitti, R. J. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02081.x · Cited by 19
Switching and combining of dopamine agonists
Junghanns, S., Gl�ckler, T., & Reichmann, H. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1605-7 · Cited by 18
Arbitrary visuomotor mapping during object manipulation in Parkinson's disease
Nowak, D. A., Ameli, M., Kemper, F., Sarfeld, A., Bensmaïl, D., Konczak, J., & Fink, G. R. (2009) · Movement Disorders · doi:10.1002/mds.22543 · Cited by 6
Cited by
Neurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Athauda, D., Maclagan, K., Skene, S. S., Bajwa-Joseph, M., Letchford, D., Chowdhury, K., Hibbert, S., Budnik, N., Zampedri, L., Dickson, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31585-4 · Cited by 889
Exenatide and the treatment of patients with Parkinson's disease
Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., Djamshidian, A., Ell, P., Soderlund, T., Whitton, P., Wyse, R., Isaacs, T., Lees, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68295 · Cited by 529
van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Metadata
- Authors
- Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2010-11-10
- Volume
- 25
- Issue
- 15
- Pages
- 2649-2653
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2089085990
- Cited by
- 4,219
- References
- 53
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.